Position in AMGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$380,949
+$116,007 QoQ
Shares Held
1,052
+39.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,374
of 3,140 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Winthrop Advisory Group LLC holds $8,653,027 across 8 Drug Manufacturers - General names. AMGN ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,894 | $2,766,749 | |
| 2 | LLY |
ELI LILLY & Co
|
1,928 | $2,312,500 | |
| 3 | ABBV |
AbbVie Inc.
|
4,944 | $1,244,107 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,931 | $1,019,133 | |
| 5 | AMGN |
Amgen Inc
This page
|
1,052 | $380,949 | |
| 6 | PFE |
Pfizer Inc
|
14,384 | $346,365 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,429 | $306,879 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,796 | $276,345 |
All Filings in AMGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $380,949 | 1,052 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $264,942 | 753 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $301,779 | 922 | Shares | Other | 2026-01-21 | |
| 2025-09-30 | $232,815 | 825 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $229,789 | 823 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $250,486 | 804 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $218,676 | 839 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $220,713 | 685 | Shares | Sole | 2024-10-31 | |
| No filing history on record for this holder in this stock. | ||||||